This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Gerald W. Chodak, MD
Louis A. Weiss Memorial Hospital Chicago, Ill

JAMA. 1995;273(15):1176.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Dr Ruffin and colleagues raise several important points. First, they are correct to emphasize that physicians should disclose the uncertainty of screening, that DRE has no more supportive evidence than PSA or TRUS, and that recommendations to screen by the ACS and American Urological Association may represent a conflict of interest.

However, I strongly disagree that Dr Krahn and colleagues¹ conclusively proved that prostate cancers creates more burden than benefit. Although the inclusion of a sensitivity analysis does show that the results of the study are consistent over a range of assumptions, the authors made no attempt to perform a multivariable sensitivity analysis, which might have significantly affected the conclusions. Even more importantly, there is no possible way to conclude from this study that screening more than once would not lead to a greater benefit. Recent studies of repeat screening have shown that patients with one normal . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?